3 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 3 |
Follow Hepatitis C Infection: new trials by email Literature Review of Hepatitis C Infection trials Research Report on Hepatitis C Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Interaction Between Paroxetine and Telaprevir Paroxetine, telaprevir - Hepatitis C Infection, Depression | Phase 2 | Terminated | Radboud University Medical Center | 3 | 2013-05-01 | 2020-12-08 |
| Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C MBL-HCV1, Telaprevir (Part 1), Sofosbuvir (Part 2) - Hepatitis C Infection | Phase 2 | Terminated | MassBiologics | 11 | 2012-11-21 | 2021-02-05 |
| Romiplostim in Treating Hepatitis C-Infected Patients With Thrombocytopenia romiplostim, ribavirin, placebo - Hepatitis C Infection, Thrombocytopenia | Phase 2 | Terminated | University of Southern California | 27 | 2010-06-30 | 2017-04-11 |
Hepatitis C (3) · Depression (1) · Thrombocytopenia (1)
Blood-Borne Infections (3) · Communicable Diseases (3) · Digestive System Diseases (3) · Flaviviridae Infections (3) · Hepatitis (3) · Hepatitis, Viral, Human (3) · Infections (3) · Liver Diseases (3) · RNA Virus Infections (3) · Virus Diseases (3) · Behavior (1) · Behavioral Symptoms (1) · Blood Platelet Disorders (1) · Cytopenia (1) · Hematologic Diseases (1)
telaprevir (2) · Paroxetine (1) · Ribavirin (1) · Sofosbuvir (1) · peginterferon alfa-2a (1) · romiplostim (1)
MassBiologics (1) · Radboud University Medical Center (1) · University of Southern California (1)
United States (2) · Netherlands (1)
David Burger, PharmD, PhD (1) · Howard Liebman (1)